AED downclassification?
This article was originally published in The Gray Sheet
Executive Summary
FDA may ask its Circulatory System Devices Panel to discuss the downclassification of automatic external defibrillators to Class II, the agency announces in the Oct. 28 Federal Register. The agency urges stakeholders to submit new safety and efficacy data on AEDs, currently designated Class III devices. A final rule downclassifying arrhythmia detectors and alarms to Class II with special controls, along with an accompanying guidance, also was issued Oct. 28. FDA announced its plans to reclassify arrhythmia detectors and alarms in December 2002, responding to petitions from AdvaMed, Quinton Instrument and Zymed Medical Instrumentation (1"The Gray Sheet" Dec. 23, 2002, p. 24)...
You may also be interested in...
AEDs Separated From Arrhythmia Detector, Alarms Under Proposed Rule
FDA intends to recommend automated external defibrillators (AEDs) for reclassification "at a later time," according to a proposed rule downclassifying arrhythmia detectors and alarms from Class III to Class II with special controls
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.